JL

Jaya Lakshmi Polimetla

Active Director Director DIN 11175688
DIN 11175688 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jaya Lakshmi Polimetla

Data last updated:

Jaya Lakshmi Polimetla is a Director at Daxon Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11175688
Primary Designation Director
Industry Pharma
First Appointment 30 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jun 20252025Active

Board colleagues of Jaya Lakshmi Polimetla

NameDINCompanyDesignation
Vimal Polimetla11175687Daxon Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Daxon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jaya Lakshmi Polimetla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaya Lakshmi Polimetla

Jaya Lakshmi Polimetla currently holds 1 directorship: Daxon Pharmaceuticals Private Limited (Director, since 30 Jun 2025).

Jaya Lakshmi Polimetla was first appointed on 30 Jun 2025 as Director at Daxon Pharmaceuticals Private Limited.

The current boards of Jaya Lakshmi Polimetla's companies include Vimal Polimetla (Daxon Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available